Replay – Indian Testing Trends free webinar from HPCI India 2025
3 March 2025
Exclusive webinar in English
👉 Click here to watch the replay
Discover the latest evaluation trends and innovations in preclinical trials and clinical studies.
⭐Our speakers for this webinar:
- – Florence Bernardin – Asia Cosme Lab
- – Guido Mariotto – Miravex
- – Edouard Macé – Eotech
Eotech presentation - – Dr Simran Sethi – Cliantha Research
Cliantha Research presentation - – Anne Charpentier – Skinobs
Skinobs was exhibiting for the first time at HPCI India, in Mumbai, booth E10, on February 18th and 19th, 2025. As part of We Are Testing, Eotech and Miravex were co-exhibiting with Skinobs, while Cliantha Research is a sponsor.
During this trip, Anne Charpentier was delighted to visit various laboratories and to learn more about the infrastructure and services offered by laboratories in the Mumbai, Ahmedabad and Bangalore regions. In addition, meetings with experts in the field of testing at the show are a direct source of information on this fast-growing market.
📍 The co-exhibitors during HPCI India 2025
Eotech offers complementary solutions for surface characterization and 3D scanning. Eotech also develops its own solutions, where you will find all its knowledge and skills to best meet customer applications.
Learn more.
Miravex is an Irish company specialized in the areas of optics, image analysis and software engineering. A highly innovative company, Miravex has introduced a new concept in skin imaging with the Antera 3D camera, and has established itself as one of the leading providers of cameras for skin analysis worldwide.
Learn more.
🚩 The sponsor of the booth
Cliantha Research, a full-service Clinical Research Organization (CRO), provides comprehensive and integrated offerings in Early Phase (BA-BE & Phase I), Late Phase (II-IV), Respiratory, Tobacco Research, Dermatology, Consumer Research, Research Lab, IVRT, Biometrics, Medical Services, Environmental Exposure Chambers (EECs).
Learn more.


You must be logged in to post a comment.